|
|
|
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Amended Notice
To reflect a change in the Date
of the meeting.
| Center | Date | Time | Location |
|---|---|---|---|
| CDER | March 13, 2006 | 8:00 a.m. - 5:00 p.m. | Gaithersburgh
Hilton |
Background material and meeting information will become available no later than one business day before the meeting (Simply scroll down to the appropriate committee heading).
Notice:
The Food and Drug Administration (FDA) is announcing an amendment to the notice
of the meeting of the Oncologic Drugs Advisory Committee. This meeting was announced
in the Federal Register of January 6, 2006 (71 FR 943). The amendment is being
made to reflect a change in the Date and Time portion of the document.
The date of this meeting is being changed. There are no other changes.
Supplementary Information:
In the Federal Register of January 6, 2006, FDA announced
that a meeting of the Oncologic Drugs Advisory Committee would be held on March
15, 2006, from 8 a.m. to 5 p.m. On page 943, in the 2nd column, the Date
and Time portion of the document is amended to read as follows:
Date and Time:
The meeting will be held on March 13, 2006, from 8 a.m.
to 5 p.m.
Contact Person:
Johanna M. Clifford, Center for Drug Evaluation and Research
(HFD-21), Food and Drug Administration, 5600 Fishers Lane, (for express delivery,
5630 Fishers Lane, Rm. 1093) Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776,
e-mail: cliffordj@cder.fda.gov